204 related articles for article (PubMed ID: 9042993)
1. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study.
de Groot GH; de Both PS
Aliment Pharmacol Ther; 1997 Feb; 11(1):193-9. PubMed ID: 9042993
[TBL] [Abstract][Full Text] [Related]
2. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial.
Yeoh KG; Kang JY; Tay HH; Gwee KA; Tan CC; Wee A; Teh M; Choo HF; Chintana-Wilde W
J Gastroenterol Hepatol; 1997 Jan; 12(1):13-8. PubMed ID: 9076616
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cisapride therapy in functional dyspepsia.
Kellow JE; Cowan H; Shuter B; Riley JW; Lunzer MR; Eckstein RP; Höschl R; Lam SK
Aliment Pharmacol Ther; 1995 Apr; 9(2):153-60. PubMed ID: 7605855
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
al-Quorain A; Larbi EB; al-Shedoki F
Scand J Gastroenterol; 1995 Jun; 30(6):531-4. PubMed ID: 7569759
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
7. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
[TBL] [Abstract][Full Text] [Related]
8. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial.
Fumagalli I; Hammer B
Scand J Gastroenterol; 1994 Jan; 29(1):33-7. PubMed ID: 8128175
[TBL] [Abstract][Full Text] [Related]
9. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
Wood SF; Penney SC; Cochran KM
Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
[TBL] [Abstract][Full Text] [Related]
11. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
13. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.
Frazzoni M; Lonardo A; Grisendi A; Della Casa G; Pulvirenti M; Ferrari AM; Di Gregorio C; Melini L
J Clin Gastroenterol; 1993 Sep; 17(2):101-8. PubMed ID: 8409311
[TBL] [Abstract][Full Text] [Related]
14. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies.
Kearney DJ; Avins AL; McQuaid KR
Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
[TBL] [Abstract][Full Text] [Related]
18. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
[TBL] [Abstract][Full Text] [Related]
19. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.
Miwa H; Hirai S; Nagahara A; Murai T; Nishira T; Kikuchi S; Takei Y; Watanabe S; Sato N
Aliment Pharmacol Ther; 2000 Mar; 14(3):317-24. PubMed ID: 10735925
[TBL] [Abstract][Full Text] [Related]
20. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
